Navigation Links
Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
Date:1/29/2009

Thursday, February 5th, 10:00 a.m. EST

WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, February 5th, 2009 at 10:00 a.m. EST, to report third quarter fiscal year 2009 financial results and to provide a quarterly update of the Company.

This call is being webcast by Thomson/CCBN and can be accessed via Repligen's website at www.repligen.com. If you are unable to access the webcast via the internet, you may also listen to the live broadcast by calling (866) 383-8008 for domestic calls and (617) 597-5341 for international calls. Participants must provide the following passcode: 88957320. For those who cannot participate in the live conference call, an archive of the audio webcast will be available shortly after the call and may be accessed at www.repligen.com.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
2. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
3. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
4. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
5. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
6. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
7. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
8. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
9. Omnitura Therapeutics Announces Private Placement Financing
10. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
11. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... NEW YORK , Feb. 26, 2015 ... commenced Factual Stock Report coverage on MabVax Therapeutics ... Inc. (MBVX) is a clinical stage biotechnology company focused ... address unmet medical needs in the treatment of cancer. ... products based on the protective immune responses generated by ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript,s ... judgment notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... sciences company that develops and commercializes proprietary technologies and ... and operational results for the fiscal first quarter ended ... are in Canadian dollars (CAD), unless otherwise stated. ... win new business from our existing customers and add ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 323andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... 12 PharmAthene, Inc. (NYSE Amex: PIP ), ... chemical threats, today reported financial and operational results for ... 2009. , For the third quarter of 2009, PharmAthene ... in the same period of 2008. For the nine ...
... McCormick School of Engineering and Applied Science at Northwestern ... of probe used in atomic force microscopy (AFM), which ... Using diamond, researchers made a much more durable ... are typically used in AFM to gather information from ...
... HAIKOU CITY, China, Nov. 11 /PRNewswire-Asia-FirstCall/ -- ... manufactures, and,markets specialty pharmaceutical products in China, today announced financial,results ... Third Quarter 2009 Financial Highlights, ... million in the, third ...
Cached Biology Technology:PharmAthene Reports Third Quarter 2009 Financial and Operational Results 2PharmAthene Reports Third Quarter 2009 Financial and Operational Results 3PharmAthene Reports Third Quarter 2009 Financial and Operational Results 4PharmAthene Reports Third Quarter 2009 Financial and Operational Results 5PharmAthene Reports Third Quarter 2009 Financial and Operational Results 6PharmAthene Reports Third Quarter 2009 Financial and Operational Results 7PharmAthene Reports Third Quarter 2009 Financial and Operational Results 8New nanocrystalline diamond probes overcome wear 2China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 2China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 3China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 4China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 5China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 6China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 7China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 8China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 9
(Date:2/25/2015)... 2015  ABC Financial Services (ABC), the leading ... and Fitness Industry, today announced enhancements to their ... latest upgrade includes advances to the agreement section ... via Identity One fingerprint biometrics. The features will ... displays at the International Health, Racquet & Sportsclub ...
(Date:2/24/2015)... YORK , Feb. 24, 2015 This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the ... provided for these markets. Market data and analytics are derived ...
(Date:2/24/2015)... 24, 2015 This report analyzes the worldwide markets for ... Face Biometrics, and Voice Biometrics. The report provides separate comprehensive analytics ... , Europe , Asia-Pacific ... , and Latin America . Annual estimates ... a seven-year historic analysis is provided for these markets. Market data ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16
... EAST LANSING, Mich. Elk and rhinoceros beetles aren,t diabetic, ... that the males are insulin-dependent. Ian Dworkin, Michigan State ... first time ever showed why horns from elk to ... to changes in nutrition. As reported in the current issue ...
... that convert electricity into methane gas could become an ... Stanford and Penn State universities. Researchers at both universities ... the remarkable ability to turn electrical energy into pure ... is to create large microbial factories to transform clean ...
... recent study led by Boston University School of Medicine (BUSM) ... role in the regulation of high fat, high cholesterol diet-induced ... online in PLoS ONE , also identify A2bAR as ... Katya Ravid, DSc/PhD, professor of medicine and biochemistry ...
Cached Biology News:Microbes make 'clean' methane 2Microbes make 'clean' methane 3BUSM study identifies receptor's role in regulating obesity, type 2 diabetes 2
Rad51B...
... to Ki67 - Proliferation Marker, prediluted ... related nuclear protein, expressed by proliferating cells ... cycle (G1, S, G2 and M phase). ... Ki67 antibodies are useful in establishing the ...
... monoclonal antibody reactive against the complex IV assembly ... in growing cultured cells. SURF1 is an important ... thought to participate in the folding of subunit ... Mutations of SURF1, particularly ones that result in ...
Phenytoin-BSA Isolated IgY DFc Drug...
Biology Products: